Podcasts about breakthroughs

Social Media⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Say hi on TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Say Hi on Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email List⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----If you've been stuck, doubting your worth, or drowning in regret — this episode is your wake-up call. Henry Lawrence drops a fire-filled reminder that you are not your past. You're not the failures, the shame, or the missed chances. You are potential in motion.In this soul-shifting transmission from The Positive Mindset Podcast, you'll learn:How to break free from your history and step into your powerWhy one moment of clarity can define your legacyThe spiritual truth about pressure, transformation, and becoming the diamondA guided breathwork session to lock in your highest visionThe deeper reason you're still here — and why it's not too lateClose your eyes. Breathe in. See your future self.This is the day everything shifts.

One Big Question Podcast I "“From Bandages to Breakthroughs: The Evolution of Wound Care"From bandages and guesswork to biotech, smart dressings, and data-driven healing — wound care has officially entered its innovation era.From Bandages to Breakthroughs isn't just a timeline, it's a testament to what happens when science, compassion, and technology stop playing small. We've moved beyond treating wounds to understanding healing at the cellular level — faster recoveries, better outcomes, and dignity for patients who deserve more than “good enough.”Progress didn't happen overnight. It happened because clinicians questioned old methods, researchers pushed limits, and innovators refused to accept stagnation. The future of wound care? Smarter, more personalized, and built to heal people, not just injuries.#FromBandagesToBreakthroughs #WoundCareInnovation #FutureOfHealthcare #MedicalAdvancement #HealthTech #ClinicalExcellence #HealingScience #InnovationInMedicine #NextGenHealthcare #MedTechMovement

Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today.  We've created a new chapter, ‘The Adventure of the Silent Hiss', to ‘The Return of Sherlock Holmes' collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery.  Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives. Whether cancer comes at the beginning, middle or end of a person's life, it is never the whole story and does not need to define it.  This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional. PP-UNP-GBR-13946  / December 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Marc Kramer, host of the award winning The Best Business Minds, interviews Paul Sloane author of "The Art of Unexpected Solutions: Using Lateral Thinking to Find Breakthroughs"

This episode of The AI Report dives into a wild, high‑stakes week in artificial intelligence, as told by your favorite synthetic anchors, Artie Intel and Micheline Learning. From Hollywood power plays to life‑saving lab breakthroughs, the future is arriving fast, and it brought receipts. Artie and Micheline kick things off in Tinseltown, where Disney throws down a billion‑dollar AI deal with OpenAI while blasting Google over alleged copyright abuses, reshaping the rules of who gets paid when AI learns from blockbuster IP. Then they shift to Washington, D.C., breaking down President Trump’s new executive order to centralize AI regulation at the federal level, explaining why Big Tech is cheering, civil‑rights advocates are nervous, and what a “single national AI rulebook” means for startups, states, and ordinary users.​ From there, The AI Report races through the hottest new AI tools transforming business, marketing, and creative work, from always‑on email and calendar agents to video, design, and avatar platforms that let tiny teams operate like global studios. In the “wow” segment, they spotlight jaw‑dropping breakthroughs: AI‑enhanced medical imaging that spots deadly problems earlier, chip‑inspection systems that catch microscopic defects, wearable brain–computer interfaces empowering paralyzed users, and sketch‑to‑3D agents that turn simple drawings into full models.​ Whether you’re a creator, founder, policymaker, or just trying to keep up with the robots, this episode gives you the stories, stakes, and context behind the headlines, without the hype, and with just enough attitude to keep it fun.

The final Fed meeting of 2025 delivered a surprise rate cut, but the real story is how the market is reacting. In this week's Weekly Rollup, Ryan and David unpack what the new policy shift means for crypto liquidity, why regulators across the SEC, CFTC, and OCC are suddenly embracing onchain markets, and how Tom Lee's massive ETH accumulation is reshaping sentiment. We also get into Ethereum's growing momentum from ZK advancements and blob upgrades, the ZKsync Atlas rollout, Base's bridge drama with Solana, and Farcaster's pivot away from social. Plus, the rise of tokenization, new prediction market rails, and whether this week marks the first real cycle turn for Ethereum. ------

What does it take to build something genuinely new inside a $60B Enterprise? In this podcast hosted by Sid Shaik, Outshift by Cisco VP & CPO Papi Menon breaks down how product leaders can drive meaningful innovation inside massive enterprises, and why the future depends on incubating bold bets like agentic AI and quantum networking. He shares how to identify ideas worth pursuing, how to navigate internal pressure from sales and the board, and how to create strategic optionality that reshapes a company's trajectory. This is essential listening for product leaders looking to understand what high-stakes innovation actually demands.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a myriad of transformative advancements and strategic shifts within these industries, illustrating the profound impact of innovation and regulatory changes on healthcare.Eli Lilly's recent strides in obesity treatment highlight a significant scientific breakthrough with their novel drug, retatrutide. Currently in phase 3 trials, this triple agonist targets GLP-1, GIP, and glucagon receptors, achieving an extraordinary 28.7% weight loss in participants. Additionally, it demonstrated a 75.8% reduction in knee osteoarthritis pain. Yet, the journey to this milestone wasn't without challenges. The trials saw a higher discontinuation rate than earlier studies, reminding us of the delicate balance between efficacy and patient tolerability—a consistent theme in obesity pharmacotherapy as developers strive to maximize benefits while minimizing adverse effects.In a testament to the global nature of drug development, Zealand Pharma has embarked on a $2.5 billion collaboration with a burgeoning Chinese biotech firm. This partnership aims to advance oral cardiometabolic therapies, underscoring the crucial role of strategic alliances in accessing innovative scientific platforms and expanding market reach.Rezolute faced a significant setback with a disappointing phase 3 trial for its hypoglycemia treatment, resulting in an 87% drop in stock value. This starkly illustrates biotech's inherent volatility and the critical importance of robust clinical trial design to mitigate financial risks associated with unsuccessful outcomes.Meanwhile, Moderna is leveraging Nanexa's expertise in long-acting formulations to enhance injectable therapy delivery systems. This collaboration is indicative of a broader industry trend focused on optimizing drug delivery technologies to boost efficacy and patient compliance.Operational restructuring is also evident as Pfizer implements cost-cutting measures, including layoffs in Switzerland, as part of broader strategic initiatives to optimize operations amid rising R&D costs and pricing pressures. Simultaneously, Chris Boulton's transition from Amgen to Prolynx underscores the fluid movement of talent within the industry—a reflection of ongoing strategic realignments.Regulatory landscapes are shifting as well. The FDA's approval of the first non-drug at-home treatment for depression marks an expansion into alternative therapeutic modalities beyond traditional pharmaceuticals. This wearable device offers adults with major depressive disorder a novel treatment option, integrating technology into mental health care—a promising addition to holistic treatment strategies.In another significant regulatory update, Teva Pharmaceuticals agreed to delist numerous patents from the FDA's Orange Book following an FTC ruling. This move is anticipated to foster increased generic competition and potentially lower medication costs for conditions like asthma and diabetes—a critical shift towards greater market accessibility.The FDA has also finalized guidance on promotional materials for biologics and biosimilars, standardizing advertising practices to ensure accurate representation of these products' efficacy and safety profiles amidst an expanding biologics market.Moreover, the FDA has launched its Commissioner's National Priority Voucher Pilot Review Program to expedite critical drug approvals. The first beneficiary under this program was USAntibiotics with Augmentin XR, signaling a potential shift towards more rapid access to essential medications.On the international policy front, recent developments between the UK and US have led to reductions in medicine rebate rates within the UK. This adjustment could lead to increased spending on new medicines, indicating more favorable conditions for pharmaceutical Support the show

In today's episode of Every Day Is Saturday, Sam Crowley breaks down the life-changing power of “one more rep.” Whether you're in the gym, rebuilding your confidence, growing your faith, or fighting for a dream that feels out of reach, the breakthrough never comes from the first easy steps — it comes from the rep you don't want to do. The rep that burns. The rep no one sees. The rep that defines your character. Sam shares a raw, real story from his Wolverine comeback workout and explains why that final rep becomes the moment where your identity shifts and momentum returns. You'll learn how the “one more rep mindset” applies to fitness, business, relationships, and personal transformation — and why this simple discipline separates people who stay stuck from people who change their entire life. If you need motivation, clarity, or a push to get back on track, this episode will light a fire under you. Listen now and discover the small action that leads to massive breakthroughs.

More resources? ----------------------- Watch Full Episodes in my YouTube channel! https://youtube.com/@drtjahn ---------------------- Get Your Free Copy of my book, "Podiatry Profits Book: Crafting A Seven-Figure Lifestyle Practice" to grow your podiatry practice. You just cover the shipping: https://www.podiatryprofitsbook.com ---------------------- Do you want to build your dream private practice without the hassles of insurance networks? Then schedule a FREE 45-min Strategy Session with me. We will dive to look at your current practice and I will provide you with a crystal game plan for you: https://drtjahn.com/the-profit-accelerator-session/ ---------------------- I've created this EXCLUSIVE Private Facebook Group community of like-minded podiatrists who are coming together to build their DREAM PRIVATE PRACTICE, and FREE to join!! https://www.facebook.com/groups/podiatryprofits

This episode of the Physics World Weekly podcast features a lively discussion about our Top 10 Breakthroughs of 2025, which include important research in quantum sensing, planetary science, medical physics, 2D materials and more. Physics World editors explain why we have made our selections and look at the broader implications of this impressive body of research. The top 10 serves as the shortlist for the Physics World Breakthrough of the Year award, the winner of which will be announced on 18 December. Links to all the nominees, more about their research and the selection criteria can be found here. Physics World‘s coverage of the Breakthrough of the Year is supported by Reports on Progress in Physics, which offers unparalleled visibility for your ground-breaking research.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the ever-dynamic landscape of these industries, recent advancements have underscored both the scientific ingenuity and strategic foresight shaping patient care today.Pfizer has unveiled promising clinical trial data for Tukysa, indicating its potential as a first-line maintenance therapy in HER2-positive breast cancer. This development suggests that Tukysa could delay disease progression, offering patients extended survival prospects and an improved quality of life. Additionally, Pfizer's recent licensing agreement with Yaopharma for YP05002—a small molecule GLP-1 agonist currently in Phase 1 trials aimed at obesity treatment—highlights their strategic push into the rapidly evolving obesity treatment market.Meanwhile, Fondazione Telethon, an Italian nonprofit organization, has achieved a significant milestone with FDA approval for Waskyra—the first gene therapy for Wiskott-Aldrich syndrome. This ex vivo gene therapy directly targets the genetic roots of this rare disease, shifting treatment from symptomatic management to addressing underlying causes. This approval is transformative not only for patients suffering from this condition but also for the broader field of gene therapies, heralding a new era in treating rare genetic disorders.On the strategic front, Eli Lilly's decision to establish a $6 billion active pharmaceutical ingredient manufacturing facility in Huntsville, Alabama, marks a pivotal investment in U.S. manufacturing capabilities. This site will be critical in producing APIs for small molecule and peptide medicines, a testament to Lilly's commitment to meeting growing therapeutic demands while bolstering domestic production resilience—a trend gaining momentum across the industry. In oncology, Eli Lilly's Jaypirca demonstrated an impressive reduction in disease progression during Phase 3 trials for chronic lymphocytic leukemia.Biocon's acquisition of Viatris' stake in their biosimilar subsidiary exemplifies the shifting dynamics within the biosimilars market. This move allows Biocon to consolidate its market position as biosimilars gain traction as cost-effective alternatives to branded biologics. Such strategic realignments are indicative of competitive maneuvering aimed at capturing greater market share and driving down healthcare costs.Roche has made strides with compelling results from its Phase 3 trial of giredestrant, an oral selective estrogen receptor degrader showing a 30% reduction in risk for invasive breast cancer recurrence or death. The significance of this development lies in offering an oral alternative to injectable treatments, potentially improving patient adherence and reshaping standard care protocols for hormone receptor-positive breast cancer. Furthermore, Roche has achieved another regulatory milestone with its monoclonal antibody Gazyvaro gaining EU approval for treating lupus nephritis following successful Phase 3 trials.Innovation continues unabated as Formation Bio forms a new subsidiary through a $605 million deal with Lynk Pharmaceuticals. By securing rights to a next-generation immunology asset, Formation Bio positions itself at the forefront of immunological research developments. Concurrently, BioNTech and Bristol Myers Squibb have reported positive results from Phase 2 trials of Pumitamig for triple-negative breast cancer—validating bispecific antibodies' efficacy within oncology.Collaborative efforts are also reshaping industry landscapes. Bora and Corealis have partnered to create an end-to-end contract development and manufacturing organization for oral solid dose drug development. This collaboration aims to streamline processes and provide scalable solutions through a single contracting source, reflecting a shift towards integrated service models that enhance efficiencySupport the show

 ROOT & REWIRE MEMBERSHIPCONNECT WITH LORNA:---> Instagram @lorna_bingeeatingcoach---> Tiktok @lorna_bingeeatingcoach

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of transformative events shaping the future of drug development, patient care, and global healthcare strategies.**Johnson & Johnson's Multiple Myeloma Advances** Johnson & Johnson has made significant strides in the treatment of multiple myeloma with their bispecific antibody, Tecvayli. In recent trials, Tecvayli has shown remarkable promise when used in combination therapies as a second-line treatment. This development is noteworthy as it could potentially challenge the dominance of CAR-T cell therapies like J&J's Carvykti by offering a more accessible and less complex alternative. For patients, this means potentially fewer logistical hurdles and a more straightforward therapeutic option, which could drastically improve patient care standards.**Regulatory Scrutiny on RSV Vaccines** Turning to regulatory news, the U.S. FDA has intensified its scrutiny of respiratory syncytial virus (RSV) vaccines developed by pharmaceutical giants such as Merck, AstraZeneca, and Sanofi for infants. This increased oversight follows reports linking some COVID-19 vaccines to adverse effects in children. The FDA's actions highlight the ongoing necessity for vigilant safety monitoring in vaccine development, especially for vulnerable populations like infants. This is a crucial step in ensuring that vaccines designed for our youngest population are both safe and effective.**Eli Lilly's Strategic Moves in Oncology and Beyond** Eli Lilly is making waves in oncology with its BTK inhibitor, Jaypirca. Despite strong phase 3 results that support its use as a first-line treatment for chronic lymphocytic leukemia (CLL), Lilly is focusing on its application as a second-line therapy. This strategic choice reflects an astute understanding of market dynamics and therapeutic niches where Jaypirca can provide substantial benefits despite competition from established first-line treatments. Additionally, Eli Lilly continues to leverage its financial success from its weight loss drug Tirzepatide to position itself as a central player in global pharmaceutical innovation. The company's strategic investments are likely to catalyze advancements across various therapeutic areas, reinforcing its role as a key contributor to medical breakthroughs.**Legislative Impact on Biopharma** In legislative news, the Biosecure Act's incorporation into the U.S. National Defense Authorization Act marks a strategic shift towards tightening regulations on Chinese biopharma entities regarding federal contracts by 2026. This move could have profound implications for international collaborations and competition within biotechnology innovation and drug development sectors. It signals a broader trend of increased scrutiny on foreign entities in sensitive industries like biopharmaceuticals.**China's Healthcare Transformation** China's healthcare landscape is undergoing significant transformation with the inclusion of drugs from companies like Pfizer, Lilly, and J&J into its first private insurance formulary. This development could enhance access to innovative medications within China, potentially improving health outcomes and influencing global pricing strategies in the pharmaceutical industry.**Gamida Cell's Milestone in Cell Therapies** In a major milestone for cell therapies, Gamida Cell has secured a second FDA approval for its stem cell therapy Omisirge. Initially approved to reduce infection risk during hematopoietic stem cell transplantations in blood cancer patients, Omisirge's expanded indication to treat severe aplastic anemia underscores the potential of cell therapies in addressing diverse hematologic conditions.**CSL Seqirus' New Facility in Australia** In Australia, CSL Seqirus has opened a $1 billion facility dedicated to producing cell-baSupport the show

Pfizer followed up its winning $10 billion bid forobesity startup Metsera by adding another molecule to its obesity cabinet, thisone from Chinese firm YaoPharma in a deal worth up to $1.9 billion licensing deal announced Tuesday. Meanwhile, Wave Life Sciences and Structure Therapeutics may have changed the weight loss landscape with early and mid-stagedata from their candidates that analysts called “very disruptive” and “highlycompetitive,” respectively.  At the FDA, the confusion and instability continuewith the retirement of agency veteran Richard Pazdur just three weeks into hisrole as CDER director. Pazdur's exit leaves the FDA with just three veteran leaders from one year ago. The CDC similarly made headlines last week as therevamped vaccines advisory committee voted to recommend postponing the hepatitis B vaccination from birth to two months of age for some infants. Meanwhile, the Clinical Trials on Alzheimer's Disease (CTAD)conference generated excitement in the space as Roche, Eisai and others presentednew data from their respective candidates. The star of the show was Roche'snext-gen antibody trontinemab, which lowered amyloid levels below the threshold of positivity in 92%of treated patients in a mid-stage study. Meanwhile, Eisai isdetermined to buck the losing the trend in the anti-tau space. The company's etalanetugreduced all measurable forms of MTBR-tau243—a specific biomarker of tau tanglepathology in Alzheimer's—in a Phase Ib/II trial, according to an oralpresentation at CTAD.  Finally, check outthis week's deep dives in BioPharm Executive on what pharmas are learning fromthe Chinese biotech sector and how Japan's pharma industry is setting itssights on the global market.

2025 was the year love got messy...but it might be exactly what we needed to take our power back.This week, Andrea Knoche gets real about the year we just survived. From the wildest celebrity relationship highs and jaw-dropping breakups of 2025 to the behind-the-mic evolution of From Mrs. to Ms., Andrea unpacks what these stories say about our own love lives.It's a raw reflection on reinvention, self-worth, and choosing yourself as we head into 2026. If you're ready for intention over impulse, clarity over chaos, and relationships that actually align with your desires, this episode is your end-of-year reset.In this episode:1. What 2025's Biggest Celeb Breakups and Glow-Ups Reveal About Modern LoveFrom surprise engagements to long-term marriages ending, we unpack what these headline-making moments say about timing, chemistry, and the truth about relationship cycles in midlife and beyond.2. Why Reinvention Is the Real Love Story as We Head Into 2026We break down how to stop waiting for external validation, rewrite your own narrative, and choose relationships that meet your emotional standards — not societal expectations.3. How to Use the Lessons of This Year to Step Into Your Power Next YearReal talk on boundaries, emotional clarity, and self-sourced confidence so you can walk into 2026 with intention, alignment, and a whole new kind of main-character energy.And so much more...Looking for Andrea?Instagram: @from.mrs.2.msTikTok:@from.mrs.2.msWebsite: www.frommrs2ms.comEmail: Andrea@FromMrs2Ms.comYouTube: @FromMrs2Ms Hosted on Acast. See acast.com/privacy for more information.

Across industries, teams are solving massive, complex challenges — but too often, those breakthroughs stay hidden inside their organizations. The IISE Innovation Cup, sponsored by the University of Tennessee Knoxville, changes that. It gives teams a global stage to showcase measurable results, real-world impact, and the power of industrial and systems engineering in action.In this episode of Problem Solved, we take you inside the Innovation Cup- what it is, why it matters, and what great innovation truly looks like.You'll hear from: • Tom Mazzone, Innovation Cup committee member, on why the Cup exists and how it elevates ISE work • Aniket Ramekar (Mayo Clinic), on the digital door-sign project that transformed clinical workflows • Rishabh Bhandawat (Smurfit WestRock), on optimizing spare-parts inventory • Bill Harrington, Innovation Cup committee member, on the criteria that separate a good project from a great oneWhether you work in healthcare, manufacturing, supply chain, aerospace, or continuous improvement, this episode will inspire you to look at your systems in a new way — and maybe even submit your own project.Submissions for the IISE Innovation Cup are now open.Learn more about the IISE Innovation Cup.Bill Harrington's unedited interview on IISE Innovation Cup judging criteria:https://youtu.be/fHlwnq74HqwMake sure you subscribe to Problem Solved so you never miss an episode!Learn more about The Institute of Industrial and Systems Engineers (IISE)Problem Solved on LinkedInProblem Solved on YouTubeProblem Solved on InstagramProblem Solved on TikTokProblem Solved Executive Producer: Elizabeth GrimesInterested in contributing to the podcast or sponsoring an episode? Email egrimes@iise.org

Message from our Sponsor: Looking for top-tier talent to join your team? Call The Allred Group for your elevator recruiting needs! With a deep network and unmatched industry expertise, we quickly connect you with skilled professionals who are ready to elevate your team.  Let us handle the hiring process, so you can focus on growing your business with the best in the industry. Reach out today, and let us help you take your business to new heights!To contact us go to: http://allredgroup.comIntro: Today's episode brings together the experiences of three women as they reflect on what it means to build a career in a male-dominated trade. Featuring Erin Scott with ATIS, Emerald Kuhns with NAESA International, and Shannon Drezek with the IUEC. They share the challenges they've faced, the programs and support systems that made a difference, and the courage it takes to speak up in spaces where women are still underrepresented. They also discuss the progress happening across the industry, from growing female participation to shifting workplace culture, and the barriers that still need to be addressed for the next generation.

Hour 1 of https://RushToReason.com opens with intensity and purpose as Dr. Scott Faulkner (https://castlerockregenerativehealth.com), filling in for John Rush, teams up with expert biohacker Jeremy Sova to deliver a powerful Health and Wellness Wednesday. Together, they challenge listeners to rethink everything they believe about aging, medicine, and longevity. Why is traditional healthcare failing millions—and what happens when you step outside the system to measure, optimize, and actually reverse the damage inside your body? From cutting-edge biomarkers and rapamycin protocols to hyperbaric oxygen, VO₂ max testing, and personalized data tools like the Oura Ring, Dr. Scott and Jeremy reveal a roadmap to becoming biologically younger—no matter your age or past habits. Can a former smoker achieve elite VO₂ max numbers? Could early detection tools catch cancer before symptoms appear? And what if the secret to living longer isn't more medication, but more information? Websites mentioned: https://castlerockregenerativehealth.com/ https://ouraring.com/ https://www.questdiagnostics.com/ https://www.cancerchecklabs.com/ HOUR 2 Hour 2 explodes with cutting-edge health insight as biohacker Jeremy Sova and Dr. Scott plunge into the hidden world of mitochondria, omega-3 optimization, stem cells, and advanced cardiac imaging. Why are so many people walking around with perfect calcium scores while soft plaque silently builds toward disaster? And could AI-powered CT angiograms—with Clearly technology—be the tool that uncovers the truth before it's too late? A heart-stopping live call from Rick, whose scan revealed a 98% blockage despite minimal symptoms, becomes a turning point showcasing just how radically this new technology can save lives. From personalized biomarkers to the failures of traditional medicine, the hour exposes the cracks in America's healthcare system and reveals why functional and regenerative medicine are rising fast. Dr. Scott's raw backstory—his battle against bureaucracy, burnout, and a system that rewards silence over truth—adds emotional depth and a powerful challenge: what happens when a doctor refuses to be a coward? HOUR 3 Hour 3 of Rush to Reason ignites with Dr. Scott and expert biohacker Jeremy Sova diving into some of the most groundbreaking advances in modern regenerative medicine. What if stem cells could help a paralyzed man walk again… or reverse early Alzheimer's? What if your body could regrow neural networks once believed to be permanently damaged? And what if aging itself—telomere shortening, senescent “zombie cells,” mitochondrial decline—could be slowed, halted, or even reversed? Dr. Scott takes listeners behind the scenes of A4M, the world's largest anti-aging medical summit, where he is a featured stem-cell speaker teaching thousands of physicians global best practices. Together, he and Jeremy unpack cutting-edge research from Japan, Germany, and Israel on stem cells, plasmapheresis, and hyperbaric oxygen therapy—modalities that may radically expand healthspan and quality of life. Along the way, Dr. Scott exposes why so much breakthrough science happens outside the United States and challenges listeners to rethink a medical system built on disease management rather than healing. This is a riveting episode of Rush To Reason for anyone curious about longevity, brain restoration, or the future of medicine—and it just might change the way you think about aging forever.

Raus aus alten Strukturen – rein in dein wahres Leben.

From breakthrough AI diagnostics to personalized immunotherapy treatments, cancer care is undergoing a revolution that's already saving lives.Dr. Ross Levine, Chief Scientific Officer at Memorial Sloan Kettering, shares how new technologies are helping doctors detect cancer earlier, treat it more effectively, and transform what was once untreatable into manageable conditions. Whether you're navigating cancer personally or professionally, this conversation offers crucial insights into the future of medicine and why there's unprecedented hope in cancer treatment today.You can find Ross at: Website | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.

Today one of the most vulnerable, challenging, and meaningful videos I've ever made... A deep dive into how you can experience breakthroughs in your running and life.   This episode is different than usual. It's a presentation I recorded while trying to run a Sub 3 hour marathon and let's just say, not everything always goes exactly according to plan. It's how we respond to these situations that matters most.   This episode has many visual examples that are better experienced while watching the video, vs listening to it. It could probabably still work as a podcast too.   After about 27 minutes something unexpected happens on this run. You can either listen to it, or fast forward 6 minutes to 33 minutes, for a detailed summary and conclusions.   Watch this full video on YouTube: https://youtu.be/_Hz1zJblJ5A      CHAPTERS: 0:00 How to Run a Breakthrough  1:26 Running Advice from Eliud Kipchoge, the GOAT 1:59 What is a Running Breakthrough 4:33 Real Examples of Running Breakthroughs 5:50 The Most Common Challenges Runners Face 7:39 Understanding Healthy Heart Rate Training 9:22 5 Ways to Calculate Your Easy & Hard Zones 10:50 How to Start Heart Rate Training 11:12 The 3 Training Dials You Must Master 11:52 Finding the Right Weekly Running Volume For You 13:54 Sample Training Week (Breakdown & Structure) 16:08 My Exact Running Watch Settings 17:06 What Running Flow Is And How to Access It 20:21 The Power of Living an Unhurried Life 21:44 How Journaling Can Improve Your Running Performance 22:37 How to Handle Running Frustrations 23:21 4 Drills to Help You Run with Ease  26:30 How to Finish Strong   32:03 Crossing the Finish Line 32:29 Marathon Recap, lessons learned 34:07 How to Transform Your Running and Life      LINKS AND TOOLS MENTIONED: ► Buy my book Running Breakthroughs and get amazing book bonuses: https://florisgierman.com  ► Buy my book on Amazon Worldwide - https://geni.us/running-breakthroughs  ► HR Training Zone Calculator: https://bit.ly/hr-calculator ► MAF 180 formula: https://philmaffetone.com/180-formula/ ► Talk Test: https://youtu.be/AoB2AMUq8Wg ► Lactate Testing: https://bit.ly/3WAbI5z ► Flow Rope: https://innerunnerstore.myshopify.com/ ► Path Projects: https://pathprojects.com/ ► Join Our Personal Best Running Coaching Program: https://www.pbprogram.com     PODCASTS SHOWN: ► Kipchoge's Advice to Race Faster, For Non-Elites: https://youtu.be/7E6TNeoOC3Y ► Courtney Dauwalter's Advice to Improve Your Running: https://youtu.be/OTgwIEAN3B4 ► Kilian Jornet's Advice to Race Faster: https://youtu.be/OJZO-t6O5Bk ► Lawrence van Lingen: Unstuck Your Running: https://youtu.be/QSv1bEWjepE ► Heido Moreno From Struggling Runner to Running Success: https://youtu.be/f5DBINpRv78 ► Wiliam Barth Reveals the Truth About Low Heart Rate Training: https://youtu.be/SrI6GmzAAy4 ► Dr. Phil Maffetone Interview by Floris Gierman about Heart Rate Training, Nutrition and Recovery: https://youtu.be/_TPrenWWK9U ► How Ayako Ran Her Best Times Over 50: https://youtu.be/DI0cOUQRU1I  ► Daniel Edwards - What If You Could Shave 1 Hour Off Your Marathon Time? - https://youtu.be/n-Sr9whnctc      YOU CAN FIND ME, COACH FLORIS GIERMAN HERE:  ► My Personal Best Running Coaching Program: https://www.pbprogram.com/  ► YouTube: https://www.youtube.com/florisgierman ► Strava: https://www.strava.com/athletes/1329785  ► Instagram: https://www.instagram.com/florisgierman  ► Extramilest: https://extramilest.com/  ► Path Projects: https://pathprojects.com/flo ► Podcast: https://extramilest.com/podcast/    Affiliate Disclosure: I may earn commissions if you purchase items via my affiliate links. "As an affiliate I earn from qualifying purchases." Affiliate links do not increase cost to you. Also, you do not need to use these links. You can also search for these same items in Amazon or on any search engine/shopping site of your choice and buy/research them that way.     ABOUT THE EXTRAMILEST SHOW: A podcast and YouTube channel where host Floris Gierman interviews world class athletes, coaches and health experts on the topic of how to become a stronger, healthier and happier athlete.     More info about our Personal Best Running Coaching Program can be found at https://www.pbprogram.com.      SUBSCRIBE and hit the bell to see new videos: https://bit.ly/Flo-YT  

In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about one of the boldest ideas in modern medicine: using one-time gene editing to permanently lower cholesterol and prevent heart disease.Dr. Kathiresan shares his journey from immigrant upbringing to Harvard cardiologist, genetic researcher, biotech founder, and now leader inside a global pharmaceutical company. The conversation explores how human genetics, CRISPR base editing, lipid nanoparticle delivery, and asymmetric learning converged to create a potential lifelong solution to cardiovascular disease.They also dive deep into the ethics of gene editing, global access and pricing, early intervention versus chronic care, FDA regulatory challenges, and what the Verve–Lilly acquisition means for the future of cardiometabolic medicine.This episode is a must-listen for anyone interested in biotech innovation, gene therapy, cardiovascular disease, and the future of preventive medicine. 00:00 Introduction and Guest Welcome01:16 Sekar Kathiresan's Early Life and Education03:19 Founding Verve and Transition to Entrepreneurship05:35 The Science Behind Verve's Mission10:27 Challenges and Breakthroughs in Gene Editing20:05 Regulatory Hurdles and First Human Trials25:11 Ethical Considerations in Gene Editing27:06 Introduction to Drug Delivery and Ethical Considerations27:51 Historical Context and Pioneers in Medical Procedures28:35 Commercial and Ethical Challenges in Medicine29:32 Innovations in Cardiovascular Treatments32:49 The Role of Gene Editing in Long-term Health37:55 Strategic Partnerships and Industry Insights45:08 Reflections on the US Medical Ecosystem48:54 Conclusion and Future Outlook Keep up with Sekar Kathiresan;LinkedIn: https://www.linkedin.com/in/sekar-sek-kathiresan-3501846/Website: https://www.lilly.com/ Follow Mike Rea On;Website: https://www.ideapharma.com/X: https://x.com/ideapharmaLinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/ 

In this reflective year-end episode of the Red Delta Project Podcast, Matt dives into the three biggest lessons that transformed his training, thinking, and overall well-being in 2025. These aren't quick tips or simple fitness hacks, these are the deeper, paradigm-shifting insights that came from writing Beautiful Strength, exploring the true nature of recovery, reshaping his environment, and understanding the power of emotional conditioning.You'll learn why needing lots of recovery can be a red flag rather than a badge of honor, how curating your physical and digital environment can drastically improve your habits without relying on willpower, and why emotional conditioning may be the next frontier in building a stronger, healthier, more resilient version of yourself.If you're ready to break free of the diet and exercise rat race and step into 2026 with more clarity, confidence, and control—this is an episode you won't want to miss.Plus, don't forget to follow the ongoing RDP Fitness Advent Calendar, with daily videos from December 1–24 designed to make fitness easier and far more effective.

This week is not business as usual. We're entering December under a long void moon, heading straight into a Gemini Full Moon, a Sun–Nodes square, Mars trine Chiron, and a Mercury–Jupiter breakthrough transit that closes one chapter and opens another.If you've been waiting for clarity, movement, or a sign — this is it.✨ WATCH + STAY AHEAD OF:Longest void moon  (don't start anything new)Full Moon in Gemini at 13° (what's revealed + released)Sun square Nodes (karmic turning point)Mars trine Chiron (healing → power)Mercury trine Jupiter (third + final activation)What to do / what not to do this week

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, the landscape of the pharmaceutical and biotech industries is marked by groundbreaking scientific advancements, regulatory shifts, and strategic collaborations that promise to reshape patient care and drug development significantly.A controversy has emerged in the wake of proposed changes to U.S. vaccine regulations by Dr. Vinay Prasad, a senior FDA official. This proposal has sparked considerable opposition from 12 former FDA commissioners who argue that these regulatory overhauls could potentially undermine public trust in vaccines. Former leaders from both the CDC and FDA have expressed concerns over these proposed vaccine policy changes during an ACIP meeting, discussions that could influence future public health strategies and vaccine trust. At a time when vaccine confidence is crucial, maintaining the integrity of regulatory processes is vital to public health efforts.Leadership changes are also afoot within the FDA, as Dr. Tracy Beth Hoeg steps into the role of acting director for the Center for Drug Evaluation and Research. Her appointment signals a shift towards leaders with direct experience in public health crises. This comes amidst further internal restructuring at the FDA, including the transfer of Theresa Michele, long-standing director of the Office of Nonprescription Drugs, indicating dynamic changes within the agency.In the realm of oncology, Eli Lilly's progress with its Bruton's tyrosine kinase inhibitor, Jaypirca, is noteworthy. The drug's expanded label now includes earlier treatment stages for chronic lymphocytic leukemia and small lymphocytic lymphoma. This expansion underscores the therapeutic potential of non-covalent BTK inhibitors and may significantly improve patient outcomes by offering earlier intervention options.Geopolitical challenges are impacting the industry as WuXi AppTec, a major China-based biopharmaceutical contractor, faces scrutiny from the Pentagon amid concerns about its potential ties with the Chinese military. This development highlights the complex interplay between global security concerns and international biotech collaborations. The intersection of global security concerns continues to impact biopharmaceutical supply chains as WuXi AppTec faces increased scrutiny from U.S. authorities.On the manufacturing front, Quvara Medical's emergence as a new contract development and manufacturing organization following Buckland Group's acquisition of a Becton Dickinson facility in the UK reflects industry trends toward consolidating manufacturing capabilities to meet growing biopharmaceutical demand efficiently.AstraZeneca is enhancing its pipeline through a renewed partnership with Neurimmune for an amyloidosis asset. This collaboration, potentially worth up to $780 million, highlights AstraZeneca's strategic focus on rare diseases and underscores their commitment to expanding their therapeutic portfolio through successful alliances.Regulatory updates from the FDA propose reductions in user fees for early-stage clinical trials conducted domestically while considering additional fees for overseas developments. This initiative aims to incentivize research activities within the U.S., potentially accelerating drug discovery timelines and fostering domestic innovation.In surgical technology advancements, Medtronic's Hugo surgical robot has secured FDA clearance for procedures involving prostate, kidney, and bladder removal. This marks a significant advancement in robotic-assisted surgeries and could enhance patient outcomes across approximately 230,000 surgeries annually in the U.S.As we explore more about financial maneuvers within this sector, Royalty Pharma's $275 million financing deal for Denali Therapeutics' Hunter syndrome drug reflects confidence in Denali's pipeline pendinSupport the show

A friend of mine was telling me about an experiment that was conducted in the 1950s using rats the other day. I did some research and was absolutely fascinated by what I learned from it. Let me share it with you and some of the takeaways I think may be applicable to us in the self-storage business. **Self-Storage Turnaround Playbook** https://creatingwealththroughselfstorage.lpages.co/episode-476-four-steps-i-use-to-revive-a-self-storage-facility-non-fb/ **Startup Checklist** https://creatingwealththroughselfstorage.lpages.co/episode-475-self-storage-startup-checklist-4-steps-owners-miss/ **Cap Rate, ROI & IRR Calculator** https://creatingwealththroughselfstorage.lpages.co/episode_472_cap-roi-irr-worksheet-2/ **The 4 Critical Metrics Download** https://creatingwealththroughselfstorage.lpages.co/episode-474-4-critical-metrics/ **Five Mistakes PDF* https://creatingwealththroughselfstorage.lpages.co/episode-473-5-mistakes-new-owners-make-in-self-storage/ **Q1 2026 Virtual Self Storage Bootcamp Sign Up** https://creatingwealththroughselfstorage.lpages.co/2026-q1-live-virtual-bootcamp/ **December 6, 2025 Fast-Track Your Self-Storage Success — Free Live Webinar** https://creatingwealththroughselfstorage.lpages.co/2025-q4-webinar/ **Cap Rate, ROI & IRR Calculator** https://creatingwealththroughselfstorage.lpages.co/episode_472_cap-roi-irr-worksheet-2/ **Online Courses at The Quickstart Academy** https://TheQuickStartAcademy.com/ **Listen on Apple Podcasts** ** 5 KPIs we measure** https://creatingwealththroughselfstorage.lpages.co/top-5-kpi-ebook/ **My blog** Creating Wealth Through Self Storage **Facebook** https://www.facebook.com/markhelmselfstorage/ **Twitter** Tweets by MarkHelmSelfSt **The Storage World Analyzer** http://storageworldanalyzer.com/ **The QuickStart Academy Store** https://quick-start-academy.myshopify.com  

Bill rambles about breakthroughs, a bike ride, and the valley. (00:00) - Thursday Afternoon Podcast (30:35) - Thursday Afternoon Throwback 12-4-17 - Bill rambles about la-z-boys, college playoffs, and nosy neighbors. (01:54:06) - Anything Better Podcast - NFL Week 14 Preview with Paul Virzi. Bill went 3-1 and Paul went 2-2. They talk about the weeks games as well as crazy people in public, the scene in New Orleans, and Lane Kiffin's move. SimpliSafe: This month only, take 50% off any new system. This is one of the best prices you will ever see for SimpliSafe. Go to http://www.SimpliSafe.com/BURR Helix: Take the Helix Sleep Quiz and find your perfect mattress in under two minutes. Go to http://www.HelixSleep.com/burr for 20% off sitewide.

Legendary Stanford immunologist Dr. Ed Engleman helped create the foundations of modern cancer treatment. From early breakthroughs in immune-cell training to a brand-new discovery, Engleman explains how the immune system can now be switched on and off like circuitry, with implications for cancer, autoimmune disease, infections and more. He also breaks down his role at Vivo Capital, the global life-sciences venture firm where he evaluates and guides new biotech startups. Engleman describes how Vivo's more conservative, data-driven investment style matches his own approach: digging deep into the science, waiting for real clinical signals, and backing teams that can translate discoveries into actual drugs. A rare conversation with a scientist-founder-investor whose discoveries and companies have reshaped medicine — and who's still chasing the next breakthrough. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Lauren Ready has spent decades as a documentarian and TV journalist. Now she's become an author, using her foundation in journalism to help business leaders and others to, as she says it, reveal deeper truths. Ready joined Eric Barnes to talk about her first book, "Ask Like a Leader: A Method for Revealing Deeper Truth and Turning Blind Spots into  Breakthroughs." Ready, who is also the co-founder of Forever Ready, a video production that works with many local nonprofits and business, spent many years as a TV journalist. And her documentaries have won numerous awards.

In this episode of Parts and Labor, Angela Chaudhari, MD, hosts a panel of experts from Northwestern Medicine's Division of Gynecologic Oncology to explore the innovative role of robotic surgery in cancer care. The discussion highlights how robotic technology is improving outcomes for patients with gynecologic cancers through minimally invasive techniques, enhanced precision and interdisciplinary collaboration.The panel covers advancements in robotic systems, patient populations who benefit most from this approach, including those with high BMI, complex surgical histories, and fertility concerns, as well as the future of surgical innovation at Northwestern Medicine.This episode's panel of guests includes:• Emma L. Barber, MD, John and Ruth Brewer Professor of Gynecology and Cancer Research, Division Chief of Gynecologic Oncology and Director of Robotic Surgery.• Dario R. Roque, MD, Associate Professor of Gynecologic Oncology and Fellowship Program Director.• Jenna Z. Marcus, MD, Associate Professor of Gynecologic Oncology, Director of Robotic Simulation and Associate Fellowship Program Director.

[Guest Name] is the [Title] of the [Company Purpose/offering] company [CompanyName]. [Pronoun] shares [short summary of the episode]. Three essential items that we dive into. 1️⃣ [Item 1] 2️⃣ [Item 2] 3️⃣ [Item 3] Also, watch the entire episode on youtube. [link here]Links:[Company Name]Website: Linkedin: Facebook: Instagram:Twitter: Youtube: Fintech Confidential YouTube: https://fintechconfidential.com/watch Podcast: https://fintechconfidential.com/listen Notifications: https://fintechconfidential.com/accessLinkedIn: https://www.linkedin.com/company/fintechconfidentialTwitter: https://twitter.com/FTconfidential Instagram: https://www.instagram.com/fintechconfidential Facebook: https://www.facebook.com/fintechconfidentialSupportersSupport is provided by MPC 2023, the premier event for fintech leaders. This is your chance to shake hands and rub shoulders with the world's top experts in payments, loyalty, blockchain, digital currencies, cybersecurity, consumer privacy, and other emerging fintech solutions connecting you directly with the future of commerce. If you haven't already, mark your calendars for August 23rd through the 25th and join me and Fintech Confidential at the Westin Atlanta Perimeter North. When you sign up for FinTech confidential notifications, you will receive a discount from $50 to 100% off.Or use this link for $50 of registration. https://mpcevent.com/FTC50Time Stamps:[insert timestamps from transcript]This is a Production of Diamond D3, Media ABOUT: [Guest Name]: [Guest Bio][Company Name] : [Company info]Tedd Huff: Tedd Huff is the Co-Founder of Voalyre, and the President & Founder of Diamond D3, a professional services consulting firm focused on global payments and marketing. He is also a video podcast host and producer of Fintech Confidential.Over the past 24 years, he has contributed to FinTech startups as an Advisory Board Member, Co-Founder, and Chief Experience Officer, providing strategic and tactical direction for Global Payments OpenEdge, Heartland Payments, Nuvei, and TSYS, among others, focusing on growth while delivering innovation, process improvements and user experience-driven value to simplify the complexity of payments.Diamond D3, Media: A media creation, management, and production company delivering engaging content globally

80% of a fish's diet is underwater, which means nymphing is a crazy effective way to put fish in the net. So, this week on Untangled, Spencer and Alex share everything they learned while filming their Nymphing Master Class. From insight on why fly pattern doesn't matter, to tips on picking the right strike indicator, you'll leave this episode ready to put all these tips into practice out on the water.  LINKS FROM THE SHOW Join the VFC Online Community - CHECK IT OUT QUESTIONS FOR THE SHOW - SUBMIT HERE #LIVEREELLIFE MOMENT - SUBMIT HERE VIDEO - Nymphing Master Class - CHECK IT OUT    

In this episode of Case Studies, Casey sits down with Taylor Randall, the 17th president of the University of Utah and former dean of the David Eccles School of Business. With a background as a distinguished economist and academic leader, Taylor brings deep insight into what it takes to lead major institutions through growth, innovation, and cultural transformation.He shares the leadership principles that guided his decade-long transformation of the Eccles School into a nationally recognized and fast growing business program, and discusses how those same values now shape his presidency at the University of Utah. The conversation explores how to build momentum in complex systems, why fast decision making matters, and how to lead with both humility and urgency in high stakes environments.Casey and Taylor unpack topics ranging from academic innovation and public university strategy to entrepreneurship, economics, and the future of higher education.00:00 | Welcome & Introduction to Taylor Randall01:14 | Growing Up at the University of Utah03:10 | Early Career at Arthur Andersen05:01 | Wharton Years & Ambitious Peers06:13 | Academic Curiosity & Consulting for MLB07:34 | Why Chaos Creates Opportunity08:31 | PhD Research on Global Operations Strategy10:27 | Turning Down Chicago to Return to Utah11:27 | Venture Fund & Breaking the Classroom Model13:37 | How AI Disrupts and Enhances Higher Ed14:42 | Launching Lassonde Studios & Student Startups16:59 | Building Immersive, Purpose-Driven Experiences18:50 | Early 2000s Venture Fund Success & Lessons20:31 | Inspiration Behind the Entrepreneurial Institute21:57 | Reimagining the Classroom-Incubator Hybrid22:07 | Teaming Up with Futurists and Architects23:39 | Becoming Dean During the Financial Crisis24:18 | Privatizing the Business School Model27:36 | Program Innovation & Specialized Master's Degrees30:48 | Education as a Confidence Catalyst32:25 | Mentorship, Mistakes & Growth Moments34:59 | Considering Life After Academia36:15 | Presidential Application Process & Headwinds in Higher Ed38:33 | Interviewing for President During COVID40:13 | Behind Utah's Nationally Ranked COVID Response43:36 | Lessons from the Pandemic Response Team45:43 | Understanding the University of Utah as a $9B Enterprise47:02 | Medical Education, Research, and Clinical Trials50:36 | Breakthroughs in Neurobionics & HIV Prevention52:04 | University-Owned Businesses & Innovation Ecosystem53:16 | Huntsman Cancer Institute's Impact on Utah County54:50 | Collaborative Vision Across Utah's Higher Ed Institutions55:22 | Proxima: Creating Healthcare Career Pathways57:54 | UVU, First-Gen Students & The Promise of Education59:11 | Executive Education & Adapting to a Changing Market59:26 | The Future of College Sports & Athlete Compensation01:03:20 | Sustainable Models for College Athletics Hosted on Acast. See acast.com/privacy for more information.

"Being a public company CMO is very different than being a CMO in a private entity ... you need to deliver earnings. And I'd say this, any CMO that is not focused on driving revenue will not be there a long time," says Drew Panayiotou, the CMO of Keurig Dr Pepper. "You have to drive revenue, no if, ands, or buts." Consistently driving revenue gets even harder when, like Drew, you are stewarding 125 brands, including Yoohoo, Hawaiian Punch, Canada Dry, Keurig, Dr Pepper, and 7-Up. Drew believes in focusing on building emotional connections and cultural relevancy, driving raving fans to perpetuate the brand's growth and significantly impacting revenue. Today on Building Better CMOs, he talks with Marketing + Media Alliance CEO Greg Stuart about harnessing digital transformation to fuel marketing initiatives, the importance of internal alignment and communication, and the role of emotional connections in brand loyalty. ⁠Full transcript⁠ This episode was produced and edited by Eric Johnson from ⁠LightningPod⁠⁠ Follow Building Better CMOs in your podcast app⁠⁠⁠⁠⁠ Rate and review the podcast ⁠⁠Drew's LinkedIn⁠⁠ Greg's LinkedIn

COP30 was meant to be the summit of "implementation," but what did it actually achieve?Aub dives into the core tensions and final agreement from Belém, delivering an unfiltered analysis of the outcomes - from lobbyists, to political maneuvers, to "Indigenous-washing"Reminder: shifting power, shifts power

As we wrap up 2025, Arash walks us through how to reinvent yourself before December 31st. Dive into a real and raw conversation, because who you are on the 31st will determine the momentum you carry into 2026. In this action-focused episode, Arash unpacks the rules of 30-day transformation: why your old self has to die, the importance of setting a clear intention, and how to spot the excuses keeping you stuck. He breaks down how to define the person you're becoming, shares a day-by-day example of staying accountable, and gives you a right-now, actionable step to begin your shift. If you're ready to become the biggest and boldest version of yourself in just 30 days, this is the episode you don't want to miss!Key Points From This Episode:The topic for today's podcast: reinventing yourself in just 30 days.Arash unpacks the rules for transforming in 30 days.Why you need to let the old self die.Breakthroughs don't happen randomly; you have to set an intention.He breaks down actionable steps to get listeners started on their transformation.Mykie shares two reformed behaviors that changed her life.Identifying the top four excuses and some examples of what excuses could be. Defining who you will become: one habit, one standard, three goal-achieving actions, and a transformed belief.Arash details a day-to-day example of maintaining accountability in your transformation.Stacking evidence, one day at a time.The right-now action step for today's episode.Links Mentioned in Today's Episode:Schedule a call with Monica Da Maren EmailMonica Da Maren on InstagramVoss Coaching CoVoss Coaching Co on LinkedIn Voss Coaching Co on InstagramVoss Coaching Co on FacebookMykie Stiller on LinkedInMykie Stiller on Instagram Arash Vossoughi on LinkedInArash Vossoughi on YouTube

In this groundbreaking episode of Unleashing Intuition Secrets, Michael Jaco sits down with David Schmidt, the visionary inventor, CEO, and founder of LifeWave, for one of the most revealing conversations ever captured about the future of human energy, healing, and technological evolution. With more than 200 patents worldwide, Schmidt opens up about the extraordinary breakthroughs showcased at the recent LifeWave convention in Anaheim and the divine inspiration behind his life's work. He shares how biblical codes, intuition, and advanced science have guided his research into phototherapy, stem cell activation, and regenerative technology. Michael and David explore the origins of LifeWave—the intense three-year research journey that led to wireless phototherapy communication with the body—and how innovations like the X39® stem cell activation patch emerged after a decade of scientific development. Schmidt also discusses his early engineering ventures, designing hydrogen production systems, multi-fuel turbines, and advanced propulsion technologies for military and commercial use. The conversation then moves into LifeWave's newest and most ambitious advancements, including: • The X2O water system, designed to transform water quality and supply • Next-generation energy solutions capable of powering homes • Breakthroughs in human energy production • Plans for global expansion, celebrity partnerships, and a fully evolved future for LifeWave Michael and David also highlight the incredible impact users are experiencing with LifeWave patches, the company's newly enhanced compensation plan, and how these technologies will shape the health and wellness landscape worldwide. This is a must-listen episode for anyone interested in cutting-edge healing technologies, human potential, and the powerful intersection of science and spirituality. Explore LifeWave with Michael Jaco: https://www.lifewavemichaeljaco.com Learn more about LifeWave technology and product insights: https://liveyounger.com/ Stay in the love vibrations as innovation, intuition, and healing come together to shape the future. ✨

Join Dr. Patti Farris as she welcomes Zubin Meskenpush, President and COO of Sente, to the 2025 Science of Skin Summit. Discover Sente’s revolutionary HERO technology featuring their proprietary Heparan Sulfate Analog (HSA), reshaping skincare with enhanced hydration, inflammation control, and cellular health. Dive into the science behind their new antioxidant serum, Defense C, which blends HSA with a powerful form of Vitamin C. Learn how this innovation protects against environmental stress and aging, validated by clinical and ex vivo studies. Tune in for insights on how Sente’s cutting-edge solutions are shaping the future of skincare. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment. Follow and listen to The Science of Skin Podcast: YouTube: https://www.youtube.com/@scienceofskinpodcast Apple: https://podcasts.apple.com/us/podcast/skincare-confidential/id1664286292 Spotify: https://open.spotify.com/show/49NtbRxb32CJu2XtSV6tso Amazon Music: https://music.amazon.com/podcasts/7de48e5e-f450-466b-a0f4-f2275b67757f/skincare-confidential iHeart: https://www.iheart.com/podcast/269-skincare-confidential-269540115/ Audacy: https://www.audacy.com/podcast/skincare-confidential-4398fSee omnystudio.com/listener for privacy information.

If you have ever felt like you are doing “all the things” and still not seeing progress, this poddy is for you. In this episode we invite our longtime friend and executive coach Kris Honeycutt to sit in the hot seat with us and talk straight to the woman who feels defeated in her health, hormones, weight, or even family life. Kris walked through one of the hardest valleys a mama can face and God gave her a simple “battle plan” to get out of the pit. She is sharing that with you today so you can pick up hope again. This is not another “try harder” lecture. This is about partnering with God, shifting your mindset out of orphan thinking, and learning how to stay in the journey even when the scale or your circumstances are not budging yet. In this episode we talk about: What to do when you are discouraged and ready to quit The simple three step “battle plan” Kris uses every morning Letting go of your timeline without letting go of God's promises How to invite God into your weight loss and health journey Why your 40s, 50s, and 60s are actually a powerful season, not “the end” How coaching and community can finally get you unstuck If you have ever whispered, “Maybe this just will not work for me,” come sit with us. There is hope. Join Pearl and Serene on the Trim Healthy Podcast (a.k.a. “The Poddy”). Welcome to the spot where Pearl and Serene share their knowledge and their hearts (along with Danny's antics) on topics ranging from physical and mental health to spiritual truth, and, yes… even a little comic relief. Put your seat belts on though…it can get a little bumpy! This particular show can be lacking in “proper podcast behavior.” But this is where growth happens… this is where NEW knowledge is celebrated… and fundamental knowledge is respected. Get ready for imperfectly polite conversations about health and wellness… the place where cutting edge science meets ancient wisdom. Get Pearl and Serene's latest book – Purchase Trim Healthy Wisdom and join the women that are ready to “rock 40 and beyond.”  Explore the Store:  Click here to visit Pearl and Serene's online store with over 100+ products, optimized for peak health.  Join Our Membership! Go to www.TrimHealthyMembership.com to access special series, recipes, and other exclusive content.  Get in the best shape of your life!  Access their premium workout series, Tribe Healthy, go to www.Youtube.com/TrimHealthyMama Join KIAORA:  Pearl and Serene have launched a Bioidentical Hormone Replacement Therapy tele-health company that is available in nearly every state in the USA! Go to www.KIAORA.com to learn more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Go behind the scenes of the IISE Innovation Cup, one of the most impactful showcases of industrial and systems engineering innovation. Hear from: • Tom Mazzone – Why the Cup exists • Aniket Ramekar – Gold Award winner • Rishabh Bhandawat – Silver Award winner • Bill Harrington – What judges look forDiscover how teams across industries are solving complex challenges — and what it takes to stand out.Make sure you subscribe to Problem Solved so you never miss an episode!Learn more about the IISE Innovation Cup.Learn more about The Institute of Industrial and Systems Engineers (IISE)Problem Solved on LinkedInProblem Solved on YouTubeProblem Solved on InstagramProblem Solved on TikTokProblem Solved Executive Producer: Elizabeth GrimesInterested in contributing to the podcast or sponsoring an episode? Email egrimes@iise.org

How to Heal Fertility by Starting With Gut Health What if fertility struggles aren't just about age, hormones, or luck—but about the foundation of your health: your gut? In this episode, I sit down with fertility coach and podcast host Monica Cox to break down the often-missed connection between gut health, inflammation, and reproductive challenges. Monica shares her eight-year journey through IVF, unexplained infertility, miscarriage, and the moment everything shifted: addressing food intolerances, calming her immune system, and rebuilding her health from the inside out. You'll learn why conventional fertility advice skips critical root-cause issues, how gut and cellular health affect egg quality and inflammation, and why intuition is a powerful tool in the healing process. If you're navigating fertility struggles—or supporting someone who is—this episode offers clarity, hope, and truly actionable next steps. What You'll Learn Why gut health plays a major role in fertility The truth about egg quality and inflammation What autoimmune markers can reveal The diet shifts that changed Monica's journey How stress, grief, and emotional overload impact the body Practical gut-support strategies you can start today The role of joy and intuition in healing Chapters 00:00 – Welcome Monica Cox 01:10 – Why Gut Health Matters 02:34 – Monica's IVF Journey 05:41 – Egg Quality Myths 07:28 – Autoimmune Testing & Inflammation 09:01 – Diet Changes and Breakthroughs 12:00 – Emotional Stress & Fertility 14:02 – Moving Forward After Miscarriage 16:00 – Defining Your Own Journey 19:10 – Helping Women Over 40 21:22 – Practical Gut Health Tips 24:11 – Intuition in Healing 25:21 – Importance of Joy 26:37 – Where to Find Monica Cox 27:13 – Final Thoughts & Encouragement Guest Links Monica Cox — "Finding Fertility" Podcast, website, and DMs for personalized guidance.

Have you ever worried about what you'd do if a client cried, shut down, resisted, or even got irritated during a coaching session? If you're building a coaching business, these moments can feel intimidating but they're often the very moments where the biggest breakthroughs happen.   In this episode of The Divorce Revolution Podcast, I'm breaking down exactly how to navigate emotionally charged coaching sessions without freezing, fixing, or letting your own emotions take over. I share a real behind-the-scenes moment from a recent client session where things got tense—and how I used grounding, curiosity, and space-holding to help her move from frustration to clarity. You'll also learn the difference between a breakdown and a breakthrough, how to stay regulated when your client isn't, and why your presence (not your answers) is what truly transforms people.   Resources Mentioned: The Confident Coach Certification Waitlist is the ONLY certification specifically for divorced moms who want overcome imposter syndrome and finally feel legit: https://products.ambershaw.com/certification Join the waitlist for ReNewU: https://products.ambershaw.com/signature-waitlist   What I Discuss: 01:43 A real coaching moment where things got heated 03:09 How to see emotional moments as breakthroughs, not breakdowns 06:44 Simple techniques to help your clients settle and reconnect 13:41 How the Confident Coach Certification helps you feel prepared 15:05 Final thoughts and encouragement for new coaches   Find more from Amber Shaw: Instagram: @msambershaw Website: ambershaw.com

  Surrender: The Shortcut to Your Biggest Breakthroughs   What if the solution to burnout, overthinking, and stalled momentum is not more effort — but surrender? In this solo episode, Kevin breaks down the surprising connection between surrender, emotional precision, and the highest levels of performance. You will learn why the biggest breakthroughs usually happen the moment you stop gripping so tight, and how presence creates the conditions for clarity, aligned action, and real transformation. Kevin unpacks the three tools he uses with top leaders every day — The How Effect, Brilliance over Beast, and DreamGPS — and shows you how surrender activates all three. You will leave this episode knowing how to respond instead of react, navigate your dream without burnout, and create results that feel good from the inside out. Whether you are leading a team, building a business, or just trying to get out of your own way, this episode will help you stop surviving your dream and start living it.

In this episode, I sit with Reed Davis — board-certified holistic health practitioner, certified nutritional therapist, and founder of Functional Diagnostic Nutrition — to unpack the modern health crisis and a different way forward.Reed shares his journey from environmental paralegal to leading educator in functional lab testing, why conventional bloodwork often misses the real causes, and how the DRESS framework (Diet, Rest, Exercise, Stress reduction, Supplementation) helps resolve what he calls “metabolic chaos.”We dive into real stories of transformation from clearing chronic hives and medication dependence to helping a child avoid stimulant meds through diet and lifestyle, and why running multiple, targeted labs is the “price of admission” for finding upstream healing opportunities.Reed also explains how FDN trains practitioners to interpret functional labs, design individualized protocols, and coach clients through lasting change.If you're curious about lab-led holistic care, personalized protocols, and practical steps to reclaim long-term health, this episode is for you.To learn more about FDN and connect with Reed: https://www.functionaldiagnosticnutrition.com♾ In a fast-paced world like the one we live in, time is one of our most important assets. For a few minutes every episode, I, Tannaz Hosseinpour, will be discussing topics that aim to enhance the quality of your life, by helping you feel empowered to take inspired action on your personal growth journey.Connect with me for daily insights:InstagramFacebookTikTokMore resources available on www.minutesongrowth.comThis podcast is for educational purposes only. The host claims no responsibility to any person or entity for any liability, loss, or damage caused or alleged to be caused directly or indirectly as a result of the use, application, or interpretation of the information presented herein.

In this episode, we dig into the underrated power of holiday prospecting and the strategies that help you dominate while others slow down. You'll learn how to reach buyers when their schedules loosen, how to break through with timely messaging, and how to turn seasonal objections into booked meetings. We cover the best channels to double down on, what to say in your outreach, and the mindset that turns December into a secret sales advantage. Whether you want to finish the year strong or build unstoppable momentum for Q1, this episode gives you the exact plays to execute right now.

Welcome back to another episode of Impact Theory with Tom Bilyeu! In today's episode, Tom is joined by Mason for a wide-ranging conversation just before the Thanksgiving holiday. Together, they dive deep into timely topics, exploring why the Russia-Ukraine conflict should matter to everyday Americans, the daunting prospects of America's growing national debt, and the ripple effects of foreign policy on domestic life. Tom breaks down the nuances of global alliances, the dangers and opportunities posed by rapidly advancing AI, and the ever-controversial interplay between capitalism and government intervention. The discussion also examines the limits of personal impact on massive systemic issues, the importance of meaning over money, and the real-world implications of social and political upheaval—offering insights, hard truths, and a dose of hope for listeners. Whether it's handling the economics of war, the prospects of AI superintelligence, or what keeps Tom motivated beyond financial success, this episode serves up thought-provoking commentary and practical wisdom. So grab your coffee, settle in, and get ready for a candid, insightful journey into the issues shaping our world—only on Impact Theory. Thank you to today's Sponsors: Linkedin: Post your job free at https://linkedin.com/impacttheory HomeServe: Help protect your home systems – and your wallet – with HomeServe against covered repairs. Plans start at just $4.99 a month at https://homeserve.com True Classic: Upgrade your wardrobe at https://trueclassic.com/impact Incogni: Take your personal data back with Incogni! Use code IMPACT at the link below and get 60% off an annual plan: https://incogni.com/impact CashApp: Download Cash App Today: https://capl.onelink.me/vFut/v6nymgjl #CashAppPod Business Wars: Follow Business Wars on the Wondery App or wherever you get your podcasts. Shopify: Sign up for your one-dollar-per-month trial period at https://shopify.com/impact AirDoctor: Up to $300 off with code IMPACT at https://airdoctorpro.com Learn more about your ad choices. Visit megaphone.fm/adchoices

In today's RaiseMasters Radio episode, Pat sits down with Dr. Jonny Walker to unpack how he transformed overwhelming active real estate into a freedom-focused passive investing empire. They talk about how he built the Walk of Wealth mastermind, tripled his raise volume, and why consistency, storytelling, and community changed everything for his business and family. Resources mentioned in the episode: Dr. Jonny Walker Website LinkedIn Interested in learning how to take your capital raising game to the next level? Meet us at Capital Raiser's Edge. Learn more here: https://raisingcapital.com/cre

Discover how artificial intelligence is revolutionizing heart disease prevention and treatment with Dr. Ami Bhatt, Chief Innovation Officer at the American College of Cardiology.From AI-powered early detection tools to personalized risk prediction, learn how new technologies are making quality cardiac care more accessible while preserving the essential human element of medicine. Dr. Bhatt shares fascinating insights about the innovations transforming cardiovascular health today and her vision for even more remarkable advances coming in the next five years.You can find Ami at: Website | LinkedIn | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.